None
National Institute on Drug Abuse (NIDA)
The National Institute on Drug Abuse, intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for a Conference Award to develop and implement an annual scientific meeting to advance the development of therapeutics for substance use disorders (SUDs).
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
The NOFO is expected to be published in the Winter of 2024 with an expected application due date in early 2025.
This NOFO will utilize the U13 activity code. Details of the planned NOFO are provided below.
This Notice encourages individuals with expertise and insights in the area of therapeutics development for substance use disorders (SUD) to begin to consider applying for this new NOFO when it is published. The purpose of the NOFO will be to support a Conference Award to develop and implement an annual scientific meeting that involves participants from patient advocacy organizations (PAO), academia, non-profit, industry, and government agencies such as NIDA and the FDA to advance the development of therapeutics for SUDs. The goal is to facilitate knowledge sharing, encourage communication by identifying and addressing common challenges faced by all sectors and leveraging each others expertise to find solutions, foster collaboration (e.g., developing joint projects), and facilitate transactions (e.g., licensing of compounds).
The goal is to bring together all interested stakeholders that can contribute their knowledge and expertise to accelerate the development, FDA-approval, and commercialization of safe and effective treatments for SUDs.
$100,000
One
$100,000
93.279
Applications are not being solicited at this time.
Please direct all inquiries to:
Iván Montoya, M.D., M.P.H.
Director, Division of Therapeutics and Medical Consequences (DTMC)
National Insitute on Drug Abuse (NIDA)
email: imontoya@nih.gov